About 3,4-dihydro-2H-quinoxalin-1-yl-[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone
3,4-dihydro-2H-quinoxalin-1-yl-[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone (PubChem CID 54583350) has the molecular formula C16H19N5O
and a molecular weight of 297.36 g/mol. Its IUPAC name is 3,4-dihydro-2H-quinoxalin-1-yl-[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone.
Analyze 3,4-dihydro-2H-quinoxalin-1-yl-[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 3,4-dihydro-2H-quinoxalin-1-yl-[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone?
The IUPAC name of 3,4-dihydro-2H-quinoxalin-1-yl-[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone (CID 54583350) is 3,4-dihydro-2H-quinoxalin-1-yl-[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone.
What is the SMILES notation for 3,4-dihydro-2H-quinoxalin-1-yl-[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone?
The canonical SMILES for 3,4-dihydro-2H-quinoxalin-1-yl-[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone is O=C(N1CCC(c2cn[nH]c2)C1)N1CCNc2ccccc21.
What is the InChIKey of 3,4-dihydro-2H-quinoxalin-1-yl-[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone?
The InChIKey is MOXFLCBCDLHKPP-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H19N5O/c22-16(20-7-5-12(11-20)13-9-18-19-10-13)21-8-6-17-14-3-1-2-4-15(14)21/h1-4,9-10,12,17H,5-8,11H2,(H,18,19).
What are the key properties of 3,4-dihydro-2H-quinoxalin-1-yl-[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone?
3,4-dihydro-2H-quinoxalin-1-yl-[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone has a molecular weight of 297.36 g/mol, XLogP of 2.25, 1 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 3,4-dihydro-2H-quinoxalin-1-yl-[3-(1H-pyrazol-4-yl)pyrrolidin-1-yl]methanone is sourced from PubChem (CID 54583350), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).